Kane Biotech Inc. (KNBIF)
OTCMKTS · Delayed Price · Currency is USD
0.0328
0.00 (0.00%)
Sep 25, 2025, 8:00 PM EDT
Kane Biotech Revenue
Kane Biotech had revenue of 28.00K CAD in the quarter ending June 30, 2025, a decrease of -95.49%. This brings the company's revenue in the last twelve months to 1.85M, up 144.23% year-over-year. In the year 2024, Kane Biotech had annual revenue of 2.08M with 1,296.75% growth.
Revenue (ttm)
1.85M CAD
Revenue Growth
+144.23%
P/S Ratio
4.40
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.96M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.08M | 1.93M | 1,296.75% |
Dec 31, 2023 | 148.98K | -7.75K | -4.95% |
Dec 31, 2022 | 156.73K | -1.45M | -90.25% |
Dec 31, 2021 | 1.61M | 266.20K | 19.84% |
Dec 31, 2020 | 1.34M | -351.95K | -20.78% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
AMJ Global Technology | 39.00 |
Kane Biotech News
- 18 days ago - Kane Biotech Completes Enrollment in U.S. Case Series Studies of its revyve® Antimicrobial Wound Gel and Spray - GlobeNewsWire
- 4 weeks ago - Kane Biotech reports Q2 results - Seeking Alpha
- 4 weeks ago - Kane Biotech Announces Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Kane Biotech to Present at Advanced Wound Care Summit USA - GlobeNewsWire
- 3 months ago - Philip Renaud files Early Warning Report in respect of Kane Biotech Inc. - Benzinga
- 3 months ago - Kane Biotech Announces Conversion of Demand Loan from Insider into an Unsecured Convertible Debenture and Annual General Meeting Voting Results - GlobeNewsWire
- 3 months ago - Kane Biotech Provides Further Corporate Update - GlobeNewsWire
- 4 months ago - Kane Biotech reports Q1 results - Seeking Alpha